BLACK WEEKSFlacons −15% · kits −10% · reste −5%avec le codeLivraison gratuite en Allemagne dès 200 €

Cette page a été traduite automatiquement et peut contenir des erreurs. Vous êtes de langue maternelle française ? Vos remarques et corrections sont les bienvenues.Envoyer un retour

The Peptide Desk The Peptide Desk
PT-141 Nasal, photo du produit
Sexual Health

PT-141 Nasal

Sexual Health

  • Expédié depuis l'Allemagne

Commande

Prix unitaire - Livraison gratuite en Allemagne dès 200 € pendant les Black Weeks
  • DHL avec suivi
  • Emballage discret

4.6 sur 5 sur Trustpilot73 avis

Aussi recherché sous : PT-141 Nasenspray

En un coup d'œil

PT-141 Nasal en chiffres

Les chiffres clés de notre lexique. Faites glisser le point le long de la courbe pour voir ce qui reste après une dose, par calcul.

Article complet du lexique

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~2 hours

Half-life ~2 hours
After 4 hours: 25 %
Hour 250 %Hour 425 %Hour 612.5 %Hour 103.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

About2hours

after nasal dosing (1.9 to 2.1 hours), peak levels at around 30 minutes

Class
Non-selective melanocortin agonistmainly MC4R and MC1R, plus MC3R, cyclic heptapeptide, medical name: bremelanotide
Frequency
No more than once in 24 hours and no more than 8 uses per month (the label rule for the injection)
Form
Ready-made nasal spray, 10mg in 5.4ml1.85mg/ml, about 185mcg per spray, about 50 sprays
Sizes
10 mg1 size in the shop

Il n'existe pas encore d'analyse de laboratoire pour PT-141 Nasal. Votez pourFaites-le tester vous-même, nous payons la moitiéToutes les analyses de laboratoire

Connaissances

Tout sur PT-141 Nasal

Informations détaillées bientôt disponibles.

Dosage

Chargement des informations de dosage …

Plus d'infos dans le lexique

FAQ

Questions fréquentes

Sources pour chaque réponse : article du lexique

Encore une question ?

Écrivez-nous, notre équipe vous aidera.

Is PT-141 approved?

Yes, as bremelanotide in the USA since 2019. The approval is narrow: women before menopause with acquired, generalised low sexual desire that causes distress. Not for men, not after menopause and according to the label not to enhance sexual performance.

How does PT-141 differ from PDE-5 inhibitors?

The point of action. PDE-5 inhibitors act via blood flow. Bremelanotide activates melanocortin receptors, including MC4R on nerve cells in the brain. How this leads to more desire is not clear according to the label.

What did the phase 3 trials show?

In two trials with 1,267 women in total, desire rose by 0.35 points more than on placebo after 24 weeks and distress fell by 0.33 points more. Both were statistically significant. In the open extension over 52 weeks the values stayed stable.

How long does PT-141 stay in the body?

After one dose under the skin the level peaks after about one hour, the half-life is about 2.7 hours. That fits use on demand, as the entry describes.

Which side effects were seen?

Most often nausea (40 percent versus 1.3 percent on placebo), facial flushing (20 percent) and headache (11 percent). Nausea was the most common reason for stopping. Blood pressure rose by a few mmHg for a short time after a dose.

What about dark patches on the skin?

Via MC1R bremelanotide stimulates pigment formation. Patchy darkening, including on the face and gums, was rare with dosing according to the label (about 1 percent). After up to 16 doses on consecutive days it occurred in more than a third and did not resolve in everyone.

Produits associés

Produits similaires